With the new Letter of Intent, Roche becomes a member of Medicon Village.

“This is an important milestone for us at Roche. Through this collaboration with Medicon Village, we want to become a driving force in the development of Swedish life science and contribute to solving complex challenges within the Swedish healthcare system,” says Yoshito Nakanishi, General Manager, Roche AB.

Collaboration between industry, academia, and healthcare

The collaboration focuses on addressing important challenges and opportunities through knowledge exchange, dialogue and networking, as well as policy and advocacy.

The two actors state that they want to, through the letter of intent, promote a strong ecosystem for life science innovations, improve access to new medicines and diagnostic tools and accelerate the introduction of medical innovations into clinical practice, drive innovative collaborations and strengthen knowledge exchange and networking opportunities between academia, industry and healthcare, and contribute to solving critical challenges in the healthcare system.

“The challenges we face can only be met through collaboration between industry, academia and healthcare. Here, the innovation environment at Medicon Village is an excellent arena,” says Petter Hartman, CEO, Medicon Village Innovation.